Search
Search Results
- Author(s):
- Zur, Julia, author
Tolbert, Jennifer, author
Sharac, Jessica, author
Markus, Anne, author
- Publication:
- San Francisco, CA : Henry J. Kaiser Family Foundation, July 2018
- Subject(s):
- Community Health Centers -- statistics & numerical data
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- prevention & control
Buprenorphine -- therapeutic use
Drug Overdose -- epidemiology
Inservice Training
Medicaid
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Opiate Substitution Treatment
Practice Patterns, Physicians'
Prescription Drug Misuse -- statistics & numerical data
State Government
Humans
United States
- Author(s):
- Miclette, Matthew, author
Cuan, Isabella, author
Meisel, Zachary F., author
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, August 2017
- Subject(s):
- Evidence-Based Medicine
Health Policy
Opioid-Related Disorders -- epidemiology
Opioid-Related Disorders -- therapy
Substance-Related Disorders -- epidemiology
Substance-Related Disorders -- therapy
Buprenorphine -- therapeutic use
Continuity of Patient Care
Health Services Accessibility
Inappropriate Prescribing
Insurance, Health, Reimbursement
Medicaid
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Opioid-Related Disorders -- drug therapy
Pain management
Patient Participation
Policy Making
Research
Humans
United States
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, July 2014
- Subject(s):
- Analgesics, Opioid -- therapeutic use
Buprenorphine -- therapeutic use
Comparative Effectiveness Research
Delivery of Health Care
Health Policy
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Opiate Substitution Treatment -- economics
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- rehabilitation
Analgesics, Opioid -- administration & dosage
Analgesics, Opioid -- adverse effects
Budgets
Cohort Studies
Cost-Benefit Analysis
Counseling
Criminal Law
Drug Combinations
Drug Costs
Health Services Accessibility
Insurance Coverage
Medicaid
Medicare
Patient Care Team
Patient-Centered Care
Practice Guidelines as Topic
Treatment Outcome
Humans
New England
United States
- Author(s):
- Murphy, Sean M., author
Polsky, Daniel, author
Meisel, Zachary, author
Mitchell, Julia, author
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, May 2016
- Subject(s):
- Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- economics
Buprenorphine -- therapeutic use
Cost-Benefit Analysis
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Reward
Humans
United States
- Author(s):
- Bachhuber, Marcus A., author
Weiner, Janet, author
Mitchell, Julia, author
Samet, Jeffrey, author
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, August 2016
- Subject(s):
- Opioid-Related Disorders -- diagnosis
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- epidemiology
Primary Health Care
Analgesics, Opioid -- therapeutic use
Buprenorphine -- therapeutic use
Chronic Disease
Comorbidity
Continuity of Patient Care
Delivery of Health Care, Integrated
HIV Infections -- prevention & control
HIV Infections -- transmission
Naloxone -- therapeutic use
Needle-Exchange Programs
Patient Care Management
Patient Care Team
Physician's Role
Prescription Drug Misuse
Humans
United States
- Author(s):
- Newman, Sandra, author
Fisher, Tammy, author
- Publication:
- [Oakland, Calif.] : California Health Care Foundation, January 2019
- Subject(s):
- Community Health Centers -- economics
Insurance, Health, Reimbursement
Opiate Substitution Treatment -- economics
Opioid-Related Disorders -- drug therapy
Reimbursement Mechanisms
Buprenorphine -- economics
Buprenorphine -- therapeutic use
Financing, Government
Medication Therapy Management
Primary Health Care -- economics
Value-Based Purchasing
Humans
California
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, December 3, 2018
- Subject(s):
- Analgesics, Opioid -- therapeutic use
Narcotic Antagonists -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
Buprenorphine, Naloxone Drug Combination -- therapeutic use
Cost-Benefit Analysis
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Treatment Outcome
Humans
United States
- Publication:
- Washington, DC : United States Government Accountability Office, October 2017
- Subject(s):
- Health Services Accessibility
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Outcome Assessment (Health Care)
Community-Institutional Relations
Buprenorphine -- therapeutic use
Inservice Training
Insurance Coverage
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Prescription Drug Diversion -- prevention & control
Humans
United States
United States. Department of Health and Human Services.
- Author(s):
- Elitzer, Julia, author
Tatar, Margaret, author
- Publication:
- [Oakland, Calif.] : California Health Care Foundation, September 2017
- Subject(s):
- Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- prevention & control
Buprenorphine -- therapeutic use
Comparative Effectiveness Research
Cost Savings
Drug Overdose -- drug therapy
Drug Overdose -- prevention & control
Health Care Costs
Health Services Accessibility
Healthcare Disparities
Inappropriate Prescribing -- prevention & control
Insurance Coverage -- legislation & jurisprudence
Managed Care Programs
Medicaid
Mental Health Services -- legislation & jurisprudence
Methadone -- therapeutic use
Naloxone
Naltrexone -- therapeutic use
Neonatal Abstinence Syndrome -- drug therapy
Opioid-Related Disorders -- epidemiology
Patient Care Management
Prescription Drug Diversion
State Government
Humans
California
United States
- Publication:
- Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 2, 2022
- Subject(s):
- Buprenorphine -- therapeutic use
Drug Prescriptions -- statistics & numerical data
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Opioid-Related Disorders -- drug therapy
Practice Guidelines as Topic
Scope of Practice
United States
United States. Department of Health and Human Services.
